Kaufmann M - Search Results

1

Cancer of the uterine cervix is susceptible to anti-EGF-R antibody EMD 55,900 therapy.

Solbach C, Roller M, Nicolettri M, Budischewski K, Knecht R, Kaufmann M. Solbach C, et al. Among authors: kaufmann m. Anticancer Res. 2005 Nov-Dec;25(6B):4261-7. Anticancer Res. 2005. PMID: 16309226 Free article.

2

Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer.

Solbach C, Roller M, Ahr A, Loibl S, Nicoletti M, Stegmueller M, Kreysch HG, Knecht R, Kaufmann M. Solbach C, et al. Among authors: kaufmann m. Int J Cancer. 2002 Oct 1;101(4):390-4. doi: 10.1002/ijc.10615. Int J Cancer. 2002. PMID: 12209965

3

EGF-R and Her2/neu overexpressing tumors: independent collectives for treatment of breast cancer by specific monoclonal antibody-therapy.

Solbach C, Roller M, Budischewski K, Loibl S, Nicoletti M, Stegmueller M, Kaufmann M. Solbach C, et al. Among authors: kaufmann m. J Cancer Res Clin Oncol. 2003 Apr;129(4):250-1. doi: 10.1007/s00432-003-0421-2. Epub 2003 Apr 23. J Cancer Res Clin Oncol. 2003. PMID: 12709794

4

Pituitary tumor-transforming gene (PTTG): a novel target for anti-tumor therapy.

Solbach C, Roller M, Peters S, Nicoletti M, Kaufmann M, Knecht R. Solbach C, et al. Among authors: kaufmann m. Anticancer Res. 2005 Jan-Feb;25(1A):121-5. Anticancer Res. 2005. PMID: 15816528 Free article.

5

Antitumor effect of MAb EMD 55900 depends on EGF-R expression and histopathology.

Solbach C, Sterner-Kock A, Roller M, Schnürch HG, Stegmüller M, Caspar-Bell G, Schumm-Draeger PM, Kaufmann M, Knecht R. Solbach C, et al. Among authors: kaufmann m. Neoplasia. 2002 May-Jun;4(3):237-42. doi: 10.1038/sj.neo.7900236. Neoplasia. 2002. PMID: 11988843 Free PMC article.

6

The role of early expression of inducible nitric oxide synthase in human breast cancer.

Loibl S, Buck A, Strank C, von Minckwitz G, Roller M, Sinn HP, Schini-Kerth V, Solbach C, Strebhardt K, Kaufmann M. Loibl S, et al. Among authors: kaufmann m. Eur J Cancer. 2005 Jan;41(2):265-71. doi: 10.1016/j.ejca.2004.07.010. Eur J Cancer. 2005. PMID: 15661552

7

PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence.

Solbach C, Roller M, Fellbaum C, Nicoletti M, Kaufmann M. Solbach C, et al. Among authors: kaufmann m. Breast. 2004 Feb;13(1):80-1. doi: 10.1016/j.breast.2003.09.008. Breast. 2004. PMID: 14759723

8

Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.

Spänkuch-Schmitt B, Wolf G, Solbach C, Loibl S, Knecht R, Stegmüller M, von Minckwitz G, Kaufmann M, Strebhardt K. Spänkuch-Schmitt B, et al. Among authors: kaufmann m. Oncogene. 2002 May 9;21(20):3162-71. doi: 10.1038/sj.onc.1205412. Oncogene. 2002. PMID: 12082631

9

[Sentinel lymph node biopsy in breast cancer].

Rody A, Solbach C, Kaufmann M. Rody A, et al. Among authors: kaufmann m. Chirurg. 2004 Aug;75(8):767-73. doi: 10.1007/s00104-004-0897-6. Chirurg. 2004. PMID: 15221088 German.

10

Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer.

Loibl S, Strank C, von Minckwitz G, Sinn HP, Buck A, Solbach C, Strebhardt K, Kaufmann M. Loibl S, et al. Among authors: kaufmann m. Breast. 2005 Jun;14(3):230-5. doi: 10.1016/j.breast.2004.11.005. Breast. 2005. PMID: 15927832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,401 results

Search Page

Filters